Health-007-November-2018 Related News
Dementia in Europe: a public health priority?
Following the European Commission’s decision to disband the Expert Group on Dementia, we speak to Alzheimer Europe to hear their case for a co-ordinated...
Mucopolysaccharide storage diseases and puberty and adolescence
The Medical University of Vienna’s Susanne Gerit Kircher reflects on the medical progress that has allowed people affected by mucopolysaccharide storage diseases to start...
Prudenta: an electronic solution for local literature monitoring in pharmacovigilance
Dr Polina Dombure, the managing director of Inpharmatis, introduces Prudenta, an innovative pharmacovigilance solution set to transform local literature monitoring.
The costly, time-consuming and error-prone...
Neurosteer: introducing a novel brain activity monitor
Neurosteer has developed a three-electrode neurological monitor that provides multiple brain activity biomarkers.
Neurosteer has the mission to improve the quality of brain disorder care...
Health Europa Quarterly Issue 07
Exploring the rapidly changing environment of healthcare, Health Europa Quarterly issue 07 delves into environmental and climate-related harm and discusses the evolution of medical...
Assessing the environmental risk of pharmaceuticals
AstraZeneca’s Jason Snape, outlined his company’s approach to the environmental risk assessment of human medicinal products and what more needs to be in place...
The Fool’s Tower: Europe’s oldest accommodation for mental patients
Health Europa explores with those involved in managing and expanding the then-hospital for mental patients, Vienna’s Narrenturm (Fool’s Tower).
In September, Health Europa travelled to...
Challenges and opportunities in cancer drug development
Managing director Professor Heinz Zwierzina of the Cancer Drug Development Forum talks Health Europa through the challenges in the search for new cancer drugs.
The...
Sleep and pain relief on demand, from Sana Health
Sana Health introduces its neuromodulation device, which is easing pain, improving sleep, and could save many lives.
IN 1992, the founder of Sana Health, Richard...
Medical technologies in the fight against antimicrobial resistance
Medical technologies are in a unique position to address several of the key challenges we face when thinking about antimicrobial resistance, as MedTech Europe...
It’s time for the UK to rethink its approach to medical cannabis
Producing and exporting the most amount of medical cannabis in the world - why is medical cannabis still being denied to patients in the...
In focus: rheumatoid arthritis medication and treatments
What do we know about rheumatoid arthritis medication? What are the recommended first-line treatment for this debilitating disease? Read more as Health Europa investigates.
Rheumatoid arthritis...
The Swiss perspective on mucopolysaccharide disease
Dr Fredi Wiesbauer, vice president of the Swiss Mucopolysaccharide disease (MPS) Society met with Health Europa and explored the Swiss experience of hosting such...
Towards personalised medicine: Artificial Intelligence in cancer
Dr Andrea Sottoriva introduces REVOLVER and considers the wider application of Artificial Intelligence in cancer research and care.
Developed by scientists at The Institute of...
Horizon 2020 and the Israeli Ministry of Health
Israel has enjoyed enormous success in EU framework programmes since first becoming associated in 1996. Here, Health Europa highlights the involvement of the Israeli...
HepatoPredict: stratifying liver cancer patients for transplantation
The HepatoPredict - a powerful predictive tool to accurately select hepatocellular carcinoma patients for successful liver transplantation.
Dr José Pereira Leal, the founder and executive...
Pharmacovigilance in the EU: a closer look at EudraVigilance
Health Europa highlights the role of EudraVigilance in the pharmacovigilance activities of the EMA, from the launch of the revamped system in 2017 to...
Learning from Nature: understanding sustainable antibiotic use
There is a pressing need to better understand sustainable antibiotic use and the evolution of resistance in infectious diseases.
The evolution of antibiotic-resistant pathogens poses...
New targeted methotrexate underway for rheumatoid arthritis
ROS Therapeutics APS has developed a targeted methotrexate prodrug to mitigate the side effects experienced by many rheumatoid arthritis patients.
Danish start-up company ROS Therapeutics...
MedTech SuperConnector: accelerating commercialisation in UK health sector
Health Europa introduces the MedTech SuperConnector and explores how it will help to translate promising research into commercialisation in the UK.
In April, Research England...